| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2023―Oct―30 |
SARS-CoV-2 infection induces expression and secretion of lipocalin-2 and regulates iron in a human lung cancer xenograft model |
Sangkyu Park, Dongbum Kim, Jinsoo Kim, Hyung-Joo Kwon, Younghee Lee |
| 2 |
[GO] |
2023―Sep―21 |
The N-terminal peptide of the main protease of SARS-CoV-2, targeting dimer interface, inhibits its proteolytic activity |
Sunyu song, Yeseul kim, Kiwoong kwak, Hyeonmin Lee, Hyunjae Park, Young Bong Kim, Hee Jung Lee, lin-woo kang |
| 3 |
[GO] |
2022―Sep―30 |
Establishment of the large-scale longitudinal multi-omics dataset in COVID-19 patients: data profile and biospecimen |
Hye-Yeong Jo, Sang Cheol Kim, Do-hwan Ahn, Siyoung Lee, Se-Hyun Chang, So-Young Jung, Young-Jin Kim, Eugene Kim, Jung-Eun Kim, Yeon-Sook Kim, Woong-Yang Park, Nam-Hyuk Cho, Donghyun Park, Ju-Hee Lee, Hyun-Young Park |
| 4 |
[GO] |
2022―Jan―28 |
Hyper-inflammatory responses in COVID-19 and anti-inflammatory therapeutic approaches |
Hojun Choi, Eui-Cheol Shin |
| 5 |
[GO] |
2021―Aug―31 |
MUC1-C influences cell survival in lung adenocarcinoma Calu-3 cells after SARS-CoV-2 infection |
Dongbum Kim, Sony Maharjan, Jinsoo Kim, Sangkyu Park, Jeong-A Park, Byoung Kwon Park, Younghee Lee, Hyung-Joo Kwon |
| 6 |
[GO] |
2020―Aug―31 |
Immunomodulatory effect of mesenchymal stem cells and mesenchymal stem-cell-derived exosomes for COVID-19 treatment |
Kaavya Jayaramayya, Iyer Mahalaxmi, Mohana Devi Subramaniam, Neethu Raj, Ahmed Abdal Dayem, Kyung Min Lim, Se Jong Kim, Jong Yub An, Yoonjoo Lee, Yujin Choi, Arthi Kirubhakaran, Ssang-Goo Cho, Balachandar Vellingiri |
| 7 |
[GO] |
2020―Apr―29 |
COVID-19: an update on diagnostic and therapeutic approaches |
Mahalaxmi Iyer, Kaavya Jayaramayya, Mohana Devi Subramaniam, Soo Bin Lee, Ahmed Abdal Dayem, Ssang-Goo Cho, Balachandar Vellingiri |
|
